Clinical Trial Update: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluates cenobamate for safety and efficacy in pediatric subjects aged 2-17 with partial-onset seizures; study status is active not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy
• Seizure Disorders

Drugs mentioned

• Cenobamate (cenobamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Partial Epilepsy | Phase 3 | Status: ACTIVE_NOT_RECRUITING